References
- Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
- Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther. 2007;5(2):283–294.
- Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1–134.e8.
- Shih T, Peneva D, Xu X, et al. The rising burden of preeclampsia in the United States impacts both maternal and child health. Am J Perinatol. 2015;33(4):329–338.
- ACOG Committee Opinion No. 767: summary emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019;133(2):409–412.
- Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237–e260.
- Kantorowska A, Heiselman CJ, Halpern TA, et al. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies. Am J Obstet Gynecol. 2020;223(2):250.e1–250.e11.
- Council on Patient Safety in Women’s Health Care. Severe hypertension in pregnancy patient safety bundle | Council on Patient Safety; 2021 [cited 2021 Feb 19]. Available from: https://safehealthcareforeverywoman.org/aim/patient-safety-bundles/maternal-safety-bundles/severe-hypertension-in-pregnancy-aim/
- Gupta M, Greene N, Kilpatrick SJ. Timely treatment of severe maternal hypertension and reduction in severe maternal morbidity. Pregnancy Hypertens. 2018;14:55–58.
- Shields LE, Wiesner S, Klein C, et al. Early standardized treatment of critical blood pressure elevations is associated with a reduction in eclampsia and severe maternal morbidity. Am J Obstet Gynecol. 2017;216(4):415.e1–415.e5.
- Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. BMC Med. 2013;11:141.
- Stott D, Bolten M, Paraschiv D, et al. Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension. Open Heart. 2016;3(1):e000351.
- Webster K, Fishburn S, Maresh M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366:l5119.
- Creasy R, Resnick R. Maternal-fetal medicine. Philadelphia (PA): Saunders; 1989.
- Sharma KJ, Rodriguez M, Kilpatrick SJ, et al. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low. Hypertens Pregnancy. 2016;35(1):123–128.
- Judy AE, McCain CL, Lawton ES, et al. Systolic hypertension, preeclampsia-related mortality, and stroke in California. Obstet Gynecol. 2019;133(6):1151–1159.
- Martin JN Jr., Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105(2):246–254.